Oura's Patent Pricing Defense

Oura turned patents into a pricing defense, not just a legal shield. Low cost rivals were not simply copying a ring shape, they were selling a very similar sleep and recovery workflow without the monthly fee that helps fund Oura’s software business. By forcing RingConn into a royalty bearing license and pushing Ultrahuman out of the U.S. market for months, Oura made no fee competition more expensive and less reliable at exactly the point where ring hardware was becoming interchangeable.1 2 3 4 5 6

• The RingConn outcome shows the playbook. RingConn kept selling rings and its app in the U.S., but under a multi year patent license and settlement. That means Oura did not need to remove every rival, it only needed to make rival economics include a toll back to Oura.3 4 5
• The Ultrahuman case was more punitive. The ITC found a section 337 violation, then issued a limited exclusion order and cease and desist order in August 2025. Ultrahuman’s own operating history shows why that mattered, the U.S. was 61% of revenue and the company did not return until March 2026 with a redesigned Ring PRO.1 2 6
• This matters more for Oura than for a normal device maker because its model blends hardware and subscription revenue. Oura sold about 1.3M rings in 2024 and had about 2M paying subscribers, with subscription revenue at about 20% of total. Protecting the ring form factor protects the installed base that later converts into $6 per month members.5 7 8

Going forward, Oura is likely to keep using patents as a gate around the U.S. smart ring market while growing through retail and health partnerships. That points to a market where challengers either pay to participate, redesign around Oura’s claims, or focus outside the U.S., which should help Oura preserve both premium pricing and subscription attach.2 4 5 6